Ellipse™ Single-Chamber ICD CD1275-36, CD1275-36Q, CD1277-36, and CD1277-36Q with Non-Coated
CARDIOVASCULAR
hamburger
.

Ellipse™ Single-Chamber ICD

CD1275-36, CD1275-36Q, CD1277-36, and CD1277-36Q with Non-Coated

Merlin@home Transmitter Compatible

PRODUCT HIGHLIGHTS

  • Improved shape with reduced volume and thickness
  • ShockGuard™ technology with DecisionTx™ programming designed to reduce inappropriate therapy and minimize the need for programming adjustments at implant
  • Low Frequency Attenuation filter designed to enhance sensing performance and may reduce the possibility of oversensing T-waves
  • SenseAbility™ feature provides flexibility to fine-tune programming around T-wave oversensing without decreasing sensitivity
  • DF4 connector designed to streamline defibrillation connections into a single terminal pin and reduce the number of set screws
  • Antitachycardia pacing (ATP) while charging and prior to charging in the VF zone further extends the programming options for terminating tachyarrhythmias without a high-voltage shock
  • 36 J delivered energy safety shock option can provide a greater DFT safety margin
  • DeFT Response™ technology offers the most noninvasive options for managing high DFTs
  • QHR™† chemistry battery provides greater capacity for enhanced longevity and improved charge time performance compared to previous SVO batteries

ORDERING INFORMATION

Contents: Single-chamber Implantable Cardioverter Defibrillator (ICD)


Reorder Number Dimensions (H x W x T, mm) Weight (g) Volume (cc) Connector Defibrillation Connector Sense/Pace
CD1275-36 68 x 51 x 12 66 31 DF1 IS-1
CD1275-36Q 66 x 51 x 12 67 30 DF4 DF4
CD1277-36 68 x 51 x 12 66 31 DF1 IS-1
CD1277-36Q 66 x 51 x 12 67 30 DF4 DF4

†QHR is a trademark of Greatbatch Medical


Rx Only

 

Brief Summary: Prior to using these devices, please review the Instructions for Use for a complete listing of indications, contraindications, warnings, precautions, potential adverse events and directions for use. Devices depicted may not be available in all countries. Check with your St. Jude Medical representative for product availability in your country.

 

Indications: The devices are intended to provide ventricular antitachycardia pacing and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias.

 

Contraindications: Contraindications for use of the implantable cardioverter defibrillator include ventricular tachyarrhythmias resulting from transient or correctable factors such as drug toxicity, electrolyte imbalance, or acute myocardial infarction.

 

Adverse Events: Implantation of the implantable cardioverter defibrillator, like that of any other device, involves risks, some possibly life-threatening. These include but are not limited to the following: acute hemorrhage/ bleeding, air emboli, arrhythmia acceleration, cardiac or venous perforation, cardiogenic shock, cyst formation, erosion, exacerbation of heart failure, extrusion, fibrotic tissue growth, fluid accumulation, hematoma formation, histotoxic reactions, infection, keloid formation, myocardial irritability, nerve damage, pneumothorax, thromboemboli, venous occlusion. Other possible adverse effects include mortality due to: component failure, device-programmer communication failure, lead abrasion, lead dislodgment or poor lead placement, lead fracture, inability to defibrillate, inhibited therapy for a ventricular tachycardia, interruption of function due to electrical or magnetic interference, shunting of energy from defibrillation paddles, system failure due to ionising radiation. Other possible adverse effects include mortality due to inappropriate delivery of therapy caused by: multiple counting of cardiac events including T waves, P waves, or supplemental pacemaker stimuli. Among the psychological effects of device implantation are imagined pulsing, dependency, fear of inappropriate pulsing, and fear of losing pulse capability.

 

Refer to the User’s Manual for detailed indications, contraindications, warnings, precautions and potential adverse events.

SJM-ELP-1114-0005(2)

Last Updated: January 02, 2019

You are about to exit the Abbott family of websites for a 3rd party website

Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott.


The website that you have requested also may not be optimized for your screen size.

Do you wish to continue and exit this website?

true
accessibility
© 2016 Abbott. All Rights Reserved. Please read the Legal Notice for further details.

Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

accessibility

You are about to exit the Abbott family of websites for a 3rd party website

Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott.


The website that you have requested also may not be optimized for your screen size.

Do you wish to continue and exit this website?